{"id":"https://openalex.org/W606561922","doi":null,"title":"Phenylpropanolamine : risks, benefits, and controversies","display_name":"Phenylpropanolamine : risks, benefits, and controversies","alternate_titles":[],"publication_year":1985,"publication_date":"1985-01-01","ids":{"openalex":"https://openalex.org/W606561922","mag":"606561922"},"language":"en","primary_location":{"id":"mag:606561922","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/ncid/BA14101291","pdf_url":null,"source":{"id":"https://openalex.org/S4306463770","display_name":"Praeger eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Praeger eBooks","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W606561922"],"child_works_count":0,"type":"book","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103474931","display_name":"John P. Morgan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John P. Morgan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001303710","display_name":"Doreen V. Kagan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Doreen V. Kagan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5006375388","display_name":"Jane S. Brody","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jane S. Brody","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.8421,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.96078431,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.37869998812675476,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.37869998812675476,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.08479999750852585,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11635","display_name":"Poisoning and overdose treatments","score":0.0843999981880188,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phenylpropanolamine","display_name":"phenylpropanolamine","score":1.0},{"id":"https://openalex.org/keywords/self-medication","display_name":"self-medication","score":0.7680000066757202},{"id":"https://openalex.org/keywords/drug-distribution","display_name":"drug distribution","score":0.4560000002384186},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.9509999752044678},{"id":"https://openalex.org/keywords/neurostimulation","display_name":"neurostimulation","score":0.7409999966621399},{"id":"https://openalex.org/keywords/behavioral-toxicity","display_name":"behavioral toxicity","score":0.921999990940094},{"id":"https://openalex.org/keywords/drug-abuse-liability","display_name":"drug abuse liability","score":0.7699999809265137},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6840000152587891},{"id":"https://openalex.org/keywords/vasoconstrictors","display_name":"vasoconstrictors","score":0.781000018119812}],"concepts":[{"id":"https://openalex.org/C2781399573","wikidata":"https://www.wikidata.org/wiki/Q59627745","display_name":"Phenylpropanolamine","level":2,"score":0.9604723453521729},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5437459349632263},{"id":"https://openalex.org/C2777834853","wikidata":"https://www.wikidata.org/wiki/Q96776939","display_name":"Liability","level":2,"score":0.5367923974990845},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5124147534370422},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3882639408111572},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3218805491924286},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.21514341235160828},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2112596035003662},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.07010674476623535}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:606561922","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/ncid/BA14101291","pdf_url":null,"source":{"id":"https://openalex.org/S4306463770","display_name":"Praeger eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Praeger eBooks","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2095795992","https://openalex.org/W4229844023","https://openalex.org/W2050894768","https://openalex.org/W2026291495","https://openalex.org/W2108875230","https://openalex.org/W631226345","https://openalex.org/W4302559665","https://openalex.org/W2409380765","https://openalex.org/W2399078260","https://openalex.org/W2441665429"],"abstract_inverted_index":{"Phenylpropanolamine":[0],"is":[1],"an":[2],"ingredient":[3],"of":[4,24,26,36,57,63,68,82],"many":[5],"prescriptions":[6],"and":[7,10,40,55,59,65,79,96,99,104],"over-the-counter":[8],"cough":[9],"cold":[11],"products":[12,42],"because":[13],"its":[14,84,89,100],"vasoconstrictive":[15],"properteis":[16],"decongest":[17],"the":[18,32,53,61,74,77],"stuffy":[19],"nose.":[20],"However,":[21],"a":[22],"number":[23],"reports":[25],"untoward":[27],"clinical":[28,80],"events":[29],"related":[30],"to":[31,92],"use":[33],"or":[34],"misuses":[35],"PPA":[37],"in":[38,73],"illegal":[39],"legal":[41],"has":[43],"emerged.":[44],"This":[45],"volume":[46],"contains":[47],"23":[48],"expert":[49],"papers":[50],"focusing":[51],"on":[52,60],"benefits":[54],"risks":[56],"phenylpropanolamine,":[58],"issues":[62],"self-medication":[64],"OTC":[66],"distribution":[67],"medication.":[69],"The":[70],"topics":[71],"discussed":[72],"work":[75],"cover":[76],"basic":[78],"applications":[81],"PPA,":[83],"liability":[85],"regarding":[86],"cardiovascular":[87],"texicity,":[88],"possible":[90],"relation":[91],"nervous":[93],"system":[94],"stimulation":[95],"behavioral":[97],"toxicity,":[98],"abuse":[101],"liability.":[102],"Tables,":[103],"figures.":[105]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W606561922","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
